Skip to main content
OpenTrials
Completed

NCT Number: NCT03644394

Implantable MyoElectric Sensors (IMES) for Prosthetic Control in Transhumeral Amputees

The Implantable Myoelectric Sensors (IMES) system is an investigational device intended to improve signal quality and consistency of myoelectric signals for prosthetic control in individuals suffering from an above elbow (transhumeral) amputation. The sensors pick up myoelectric signals intramuscularly and therefore signal quality is not affected from electrode replacement, perspiration, or artefacts.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

16 year–70 year

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

About this study

Implantable Myoelectric Sensors (IMES), the surgical tools implantation, and the external equipment used to control an electromechanical prosthetic device, together comprise the IMES System (investigational product, medical device).

Each IMES acts as an independent differential amplifier consisting of custom electronics housed within a biocompatible, hermetically sealed ceramic cylinder with metal end caps. The end caps serve as electrodes for picking up EMG activity during muscle contraction. Reverse telemetry (via a coil around the arm) is used to transfer data from the implanted sensor, and forward telemetry is used to transmit power and configuration settings to the sensors. The coil and associated electronics are housed within the frame of a prosthesis. A control system that sends data associated with muscle contraction to the motors of the prosthetic joints is housed in a belt-worn, battery-powered device. A cable attaches the control unit to the prosthetic frame.

An IMES is implanted into each targeted muscle that will be used to control a function of the prosthetic arm. Two IMES devices are needed for each DOF. For example, one device would control fingers opening and another device would control fingers closing.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • unilateral transhumeral amputation
  • can speak and comprehend German
  • undergone amputee rehabilitation, including being trained to wear and use a conventional myoelectric prosthesis
  • residual upper limb meets the criterions for TMR surgery

Exclusion criteria

  • Known genetic neuromuscular disorder
  • bleeding or clotting disorder
  • active implant
  • any metal fragments or metal implants located within the residual upper limb stump
  • Female patients if pregnant or breast-feeding

Treatment and study plan

Implantation of IMES sensors

Device

Surgical implantation of IMES sensors during routine surgery to improve prosthetic control

Primary outcomes

  1. Change in hand function over time

    Time frame: at 3, 6, 9 and 12 months after final prosthetic fitting

    Southampton Hand Assessment Procedure

Sponsors and collaborators

Lead sponsor

Medical University of Vienna

Other

Registry information

Acronym: TH-IMES

Important dates

Study start
2014
Primary completion
2017
Study completion
2017
First posted
Aug 23, 2018
Registry last updated
Aug 23, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.